Data Driven Behavior Intervention and Medical Outcome Evaluation of Patients' Comprehensive Monitoring
- Conditions
- Metabolic SyndromeMetabolic DisturbanceObesityMetabolic ComplicationInfectionDiabetes
- Registration Number
- NCT04966754
- Lead Sponsor
- Peking Union Medical College Hospital
- Brief Summary
During the study, the resuscitation room, general wards and ICU were installed fixed or mobile acquisition devices in the resuscitation room, the emergency department of Peking Union Medical College Hospital, and the collection platform was set up. Patients with acute diseases (infection, diabetes complications, etc.) caused by metabolic syndrome (obesity, diabetes, etc.) were selected after informed consent. All medical intervention behaviors, relevant medical records and medical outcome records within the collection scope of the device platform were collected prospectively . And regular follow-up, guidance of patients with metabolic syndrome control, while collecting all the lifestyle characteristics of patients, some patients with metabolic cabin research, and observe the relevant medical outcomes. After that, all the collected data were coded, and the influence of all lifestyle and medical behavior interventions on patients' medical outcomes was studied by artificial intelligence method.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1000
- Diabetes and / or obesity (BMI>=28).
- Emergency room / emergency ward / EICU;
- Be able to understand and agree the research protocol and sign the informed consent
- Pregnant women / lactation period;
- The estimated survival time was less than 1 year;
- Long term follow-up is not guaranteed;
- Failure to comply with the protocol or procedure;
- The collection of medical behavior data can not complete the de privacy or label after de privacy;
- Other researchers think that it is not suitable for inclusion
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of metabolic complications 6 weeks Relapse of acute metabolic disease, stability of biochemical metabolic indexes (such as glycosylated hemoglobin, BMI)
Rate of mortality 6 months 30-day and 90-day mortality. Death due to cardiovascualr complications
Complication control 3 weeks The occurrence of metabolic complications, infection and cardiovascular events
- Secondary Outcome Measures
Name Time Method Total cost of treatment 3 weeks Length of stay, length of stay in ICU, ventilator usage time
Quality of life 6 months Dynamic monitoring of quality of life through quality-of-life evaluation chart